INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Lupin Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500257	ISIN Demat INE326A01037	Book Value 531.55	NSE Symbol LUPIN	Dividend Yield (%) 0.64	Market Cap (₹ Cr.) 85,203.93	P/E 21.3	EPS 87.58	Face Value 2

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	16,967.50	14,666.50	11,258.83	11,771.67	11,055.93
Sale of Products	16,303.86	13,953.11	10,779.78	10,691.46	10,873.67
Sale of Services	154.72	363.32	263.29	567.02	27.35
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	508.92	350.07	215.76	513.19	154.91
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	16,967.50	14,666.50	11,258.83	11,771.67	11,055.93
Other Income	253.39	115.51	210.02	216.99	129.09
Total Revenue	17,220.89	14,782.01	11,468.85	11,988.66	11,185.02
Changes in Inventories	-38.35	-15.93	120.79	-242.38	-81.86
Cost of Material Consumed	3,716.72	3,407.30	3,151.20	2,816.90	2,741.22
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	1,246.85	1,633.86	1,525.70	1,892.74	1,522.95
Employee Benefits	2,312.07	2,095.51	1,934.14	1,918.16	1,695.86
Total Other Expenses	4,337.07	4,095.48	3,563.10	5,177.11	3,133.70
Manufacturing / Operating Expenses	1,682.82	1,626.93	1,603.02	1,627.54	1,525.33
Administrative and Selling Expenses	2,349.23	2,264.54	1,797.13	1,573.22	1,355.01
Other Expenses	305.02	204.01	162.95	1,976.35	253.36
Finance Costs	84.50	56.35	98.44	73.47	40.62
Depreciation and Amortization	647.69	724.75	548.34	514.19	502.83
Total Expenses	12,306.55	11,997.32	10,941.71	12,150.19	9,555.32
Profit Before Exceptional Items and Tax	4,914.34	2,784.69	527.14	-161.53	1,629.70
Exceptional Items Before Tax	-77.22	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	4,837.12	2,784.69	527.14	-161.53	1,629.70
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	4,837.12	2,784.69	527.14	-161.53	1,629.70
Taxation	864.16	458.60	101.93	27.17	371.08
Current Tax	857.12	484.05	95.89	57.80	367.10
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	7.04	-25.45	6.04	-30.63	8.23
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	-4.25
Profit After Tax	3,972.96	2,326.09	425.21	-188.70	1,258.62
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	3,972.96	2,326.09	425.21	-188.70	1,258.62
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	3,972.96	2,326.09	425.21	-188.70	1,258.62
Earning Per Share - Basic	87.10	51.10	9.35	-4.16	27.77
Earning Per Share - Diluted	86.79	50.87	9.31	-4.16	27.65
Operation Profit before Depreciation	5,646.53	3,565.79	1,173.92	426.13	2,173.15
Operating Profit after Depreciation	4,998.84	2,841.04	625.58	-88.06	1,670.32
Dividend Per Share	12.00	8.00	4.00	4.00	6.50
Dividend Percentage	600.00	400.00	200.00	200.00	325.00
Equity Dividend	547.88	364.60	181.99	181.80	294.92
Weighted Average Shares - Basic	45.61	45.52	45.47	45.40	45.33
Weighted Average Shares - Diluted	45.78	45.72	45.69	45.52	45.52